BWV_old [delisted] BWV

NASDAQ | ETF

Price
$77.50
Increased by +0.32%
Dollar volume (20D)
N/A
ADR%
14.29

Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide.

The company's lead vaccine program is BWV-101, an influenza vaccine.

It also develops BWV-201, streptococcus pneumoniae vaccine program; BWV-301, a norovirus-rotavirus vaccine program; and BWV-302, a norovirus-malaria vaccine program.

The company was founded in 2018 and is based in Cincinnati, Ohio.

Top 20 Holdings

Asset Name Sector Industry Weight
AAPL Apple Inc Technology Consumer Electronics 3.90%
MSFT Microsoft Corporation Technology Software - Infrastructure 3.18%
AMZN Amazon.com Inc Consumer Cyclical Internet Retail 2.59%
META Meta Platforms Inc. Communication Services Internet Content & Information 1.73%
JPM JPMorgan Chase & Co Financial Services Banks - Diversified 1.72%
JNJ Johnson & Johnson Healthcare Drug Manufacturers - General 1.55%
XOM Exxon Mobil Corp Energy Oil & Gas Integrated 1.44%
GOOGL Alphabet Inc Class A Communication Services Internet Content & Information 1.37%
GOOG Alphabet Inc Class C Communication Services Internet Content & Information 1.36%
BAC Bank of America Corp Financial Services Banks - Diversified 1.29%
INTC Intel Corporation Technology Semiconductors 1.09%
WFC Wells Fargo & Company Financial Services Banks - Diversified 1.02%
CVX Chevron Corp Energy Oil & Gas Integrated 1.00%
V Visa Inc. Class A Financial Services Credit Services 0.96%
PFE Pfizer Inc Healthcare Drug Manufacturers - General 0.95%
T AT&T Inc Communication Services Telecom Services 0.95%
UNH UnitedHealth Group Incorporated Healthcare Healthcare Plans 0.95%
CSCO Cisco Systems Inc Technology Communication Equipment 0.92%
HD Home Depot Inc Consumer Cyclical Home Improvement Retail 0.90%
VZ Verizon Communications Inc Communication Services Telecom Services 0.87%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY